Evidence map›Paper›PMID 31607632›Full record

ReviewTrends in parasitology2019

Understanding CD8

Eva V Acosta Rodríguez, Cintia L Araujo Furlan, Facundo Fiocca Vernengo, Carolina L Montes, Adriana Gruppi

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Dynamics and functional heterogeneity of FOXP3+ regulatory T cells in Trypanosoma cruzi infection: a systematic review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Double negative T cells (CD4Frontiers in immunology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An Update on Vaccines AgainstPathogens (Basel, Switzerland) · 2025
    Review
  12. Bystander CD8Frontiers in immunology · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Signatures of CD4Frontiers in immunology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Eva V Acosta RodríguezCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina. Electronic address: eacosta@fcq.unc.edu.ar.
Cintia L Araujo FurlanCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina.
Facundo Fiocca VernengoCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina.
Carolina L MontesCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina.
Adriana GruppiCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina.
Universidad Nacional de Córdoba · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

Antibody-secreting cells in the regulation of T cell response to Trypanosoma cruziR01AI116432 · NIAID · NATIONAL RESEARCH COUNCIL OF ARGENTINA · PI ADRIANA GRUPPI · 2015 to 2026
$1.3M
IL-17RA-signaling cytokines in the regulation of CD8 T cell immunity to T. cruziR01AI110340 · NIAID · NATIONAL RESEARCH COUNCIL OF ARGENTINA · PI ACOSTA RODRIGUEZ, EVA V · 2014 to 2018
$667k
NIAID NIH HHS R01 AI110340NIAID NIH HHS R01 AI116432
6 · The paper itself

Abstract

The protozoan Trypanosoma cruzi is the causative agent of Chagas' disease, endemic in Latin America but present worldwide. Research efforts have focused on the examination of immune mechanisms that mediate host protection as well as immunopathology during this parasitic infection. The study of CD8

Indexed as

CD8-Positive T-LymphocytesChagas DiseaseHost-Parasite InteractionsHumansResearchTrypanosoma cruziCD8(+) T cellsChagas' diseaseTrypanosoma cruzi

Identifiers

PMID31607632
PMCPMC6815727
OpenAlexW2979750350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.